• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗对新冠病毒病住院结局的影响。

Vaccine Effects on In-hospital COVID-19 Outcomes.

作者信息

Gonçalves Bronner P, Olliaro Piero L, Horby Peter, Cowling Benjamin J

机构信息

From the ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.

Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.

出版信息

Epidemiology. 2025 Sep 1;36(5):646-649. doi: 10.1097/EDE.0000000000001877. Epub 2025 Jun 17.

DOI:10.1097/EDE.0000000000001877
PMID:40525720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12303245/
Abstract

Here, we posit that studies comparing outcomes of patients hospitalized with COVID-19 by vaccination status are important descriptive epidemiologic studies, but they contrast two groups that are not comparable with regard to causal analyses. We use the principal stratification framework to show that these studies can estimate a causal vaccine effect only for the subgroup of individuals who would be hospitalized with or without vaccination. Further, we describe the methodology for, and present sensitivity analyses of, this effect. Using this approach can change the interpretation of studies only reporting the standard analyses that condition on observed hospital admission status-that is, analyses comparing outcomes for all hospitalized COVID-19 patients by vaccination status.

摘要

在此,我们认为,按疫苗接种状况比较COVID-19住院患者结局的研究是重要的描述性流行病学研究,但在因果分析方面,它们所对比的两组并不具有可比性。我们使用主分层框架来表明,这些研究仅能估计出对于无论接种与否都会住院的个体亚组的因果疫苗效应。此外,我们描述了这种效应的方法并进行了敏感性分析。采用这种方法可能会改变仅报告基于观察到的住院状态进行标准分析的研究的解释,即按疫苗接种状况比较所有COVID-19住院患者结局的分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15cf/12303245/b59a1abf0f14/ede-36-646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15cf/12303245/b59a1abf0f14/ede-36-646-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15cf/12303245/b59a1abf0f14/ede-36-646-g001.jpg

相似文献

1
Vaccine Effects on In-hospital COVID-19 Outcomes.疫苗对新冠病毒病住院结局的影响。
Epidemiology. 2025 Sep 1;36(5):646-649. doi: 10.1097/EDE.0000000000001877. Epub 2025 Jun 17.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
5
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
6
Vaccines for preventing infections in adults with haematological malignancies.用于预防血液系统恶性肿瘤成人感染的疫苗。
Cochrane Database Syst Rev. 2025 May 21;5(5):CD015530. doi: 10.1002/14651858.CD015530.pub2.
7
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.

本文引用的文献

1
A multi-country analysis of COVID-19 hospitalizations by vaccination status.多国基于疫苗接种状况的 COVID-19 住院病例分析。
Med. 2023 Nov 10;4(11):797-812.e2. doi: 10.1016/j.medj.2023.08.005. Epub 2023 Sep 21.
2
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022.2021 年 1 月至 2022 年 4 月,13 个美国州 18 岁及以上接种和未接种疫苗的成年人因 COVID-19 住院的情况。
JAMA Intern Med. 2022 Oct 1;182(10):1071-1081. doi: 10.1001/jamainternmed.2022.4299.
3
Boosters reduce in-hospital mortality in patients with COVID-19: An observational cohort analysis.
加强针可降低新冠病毒感染患者的院内死亡率:一项观察性队列分析。
Lancet Reg Health Am. 2022 Apr;8:100227. doi: 10.1016/j.lana.2022.100227. Epub 2022 Mar 17.
4
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.挪威 COVID-19 患者住院时间与入住重症监护病房和院内死亡风险的关系:一项基于登记的队列研究,比较了完全接种 mRNA 疫苗的患者与未接种疫苗的患者。
Clin Microbiol Infect. 2022 Jun;28(6):871-878. doi: 10.1016/j.cmi.2022.01.033. Epub 2022 Feb 25.
5
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
6
Causal Vaccine Effects on Binary Postinfection Outcomes.因果性疫苗对感染后二元结局的影响。
J Am Stat Assoc. 2006 Mar;101(473):51-64. doi: 10.1198/016214505000000970.
7
Principal stratification in causal inference.因果推断中的主分层
Biometrics. 2002 Mar;58(1):21-9. doi: 10.1111/j.0006-341x.2002.00021.x.
8
Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.通过潜在结果探讨临床和流行病学研究中的因果效应:概念与分析方法
Annu Rev Public Health. 2000;21:121-45. doi: 10.1146/annurev.publhealth.21.1.121.